Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2026)
Harmony Biosciences Holdings (HRMY) posted Inventory Average of $5.4 million for Q1 2026, down 14.04% sequentially from $6.3 million in Q4 2025, and down 20.47% YoY from $6.8 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Inventory Average for 7 years, with the latest figure at $5.4 million in Q1 2026.
- Quarterly Inventory Average fell 20.47% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (down 20.47% YoY) and the FY2025 annual result came in at $6.4 million, up 1.26% from the prior year.
- Inventory Average declined to $5.4 million in Q1 2026 per HRMY's latest filing, from $6.3 million in the prior quarter.
- Over five years, Inventory Average peaked at $7.1 million in Q4 2024 and troughed at $4.4 million in Q3 2022.
- A 5-year average of $5.6 million and a median of $5.4 million in 2026 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2026: Inventory Average jumped 35.05% in 2024, then decreased 20.47% in 2026.
- Over 5 years, Inventory Average stood at $4.7 million in 2022, then advanced by 10.47% to $5.2 million in 2023, then surged by 35.05% to $7.1 million in 2024, then declined by 10.95% to $6.3 million in 2025, then dropped by 14.04% to $5.4 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $5.4 million, $6.3 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 5.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.98 Mn |
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 6.28 Mn |
| Sep 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 6.24 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 6.28 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Dec 31, 2023 | 5.23 Mn |
| Sep 30, 2023 | 4.97 Mn |
| Jun 30, 2023 | 4.78 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 4.38 Mn |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 4.96 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 5.10 Mn |